A new research study by Future Market Insights (FMI) pegs global cancer supportive care products market to reach USD 32 Bn by 2030. The report titled, ‘Cancer Supportive Care Products Market’ offers in-depth insights on the future market growth, laying out strategies and recommendations that stakeholders can benefit from.
High growth and unmet needs have attracted various new players to cancer supportive care products market. About 23% of compounds in the preclinical drug pipeline were in oncology in 2000, and the number increased to 38% in 2019.
This is increasing the market competition with regards to clinical-trial recruitment – for instance, the number of breast-cancer patients needed for active clinical trials is surpassing the yearly figure of diagnoses.
To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2550
Efforts to manage drug expenditure have channelized the focus towards cancer supportive care products, especially in developed regions, where value-based health-technology assessments (HTAs) are prevalent.
The cancer supportive care products market is characterized by rapidly growing and globalized standard of medical care. Case in point, in non-small-cell lung cancer, the number of approved therapies was estimated to rise from 14 in 2009 to 22 by 2019.
This, coupled with limited data during accelerated approvals, implies that manufacturers are working in close collaboration with payers to create value proposition of cancer supportive care products.
Key Takeaways of Cancer Supportive Care Products Market Study
- Incidences of cancer have surged by around 26% among geriatric demographics compared to 10% among the remaining population
- Adoption of cancer supportive care products to remain prominent in treating lung cancer
- Pharma companies to invest 30% of their spending in cancer R&D to launch novel drugs and therapies in marketplace
- Market in Asia Pacific (APAC) to experience meteoric growth through 2030
COVID-19 Impact on Cancer Supportive Care Products Market
The COVID 19 pandemic has touched every facet of human life including, healthcare delivery for chronic disorders.
As such, these patients are highly susceptible to getting infected from COVID-19 due to their compromised immunity, putting cancer specialists and patients in a dilemma.
Several healthcare facilities are deferring “elective” screenings, surgeries, and other methods that are considered not urgent or not immediately fatal.
Such important decisions are taken on a case-to-case basis to make sure patients diagnosed with cancer are protected from contracting the coronavirus as well as to ensure that healthcare facilities are equipped with resources necessary to treat cancer patients who do get affected by the virus.
The COVID-19 crisis has disturbed the treatment pathways and in-progress care, thus, resulting in temporary drop in demand for cancer supportive care products.
Cancer Supportive Care Products Market – Competitive Intelligence
The cancer supportive care products market is highly competitive, with presence of several small- and medium-sized players. Manufacturers are leveraging innovation into their best practices in order to have proper capabilities in place and stay ahead in the fast-growing and competitive arena.
- Baxter International Inc. develops products under the business categories – Renal Care, Medication Delivery, and Pharmaceuticals. The company develops REGLAN Injection, which is a metoclopramide injection.
- Amgen Inc. makes and provides innovative human therapeutics – Neulasta, which is a PEGylated form of human granulocyte CSF.
Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2550
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com